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Abstract 
 
  
  
The Smurf2 gene in mice encodes a protein that mediates ubiquination and 
degradation of a germinal center transcription factor responsible for B-cell proliferation. 
Knockouts of the Smurf2 gene have been shown in our lab to increase the formation of 
Diffuse Large B-Cell Lymphomas. The purpose of this project was to clone and sequence 
the VH4 intron locus in the DNA from the germinal centers of spleens from Smurf2-KO 
mice to determine whether they have an increased DNA mutation rate prior to tumor 
formation.  The cloning of the DNA was unsuccessful, indicating a need to conduct 
further experiments.  
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Background 
 
Diffuse Large B-Cell Lymphoma 
 Diffuse Large B-Cell Lymphoma is the most common type of Non-Hodgkin 
Lymphoma, comprising about thirty percent of all cases of the disease (Morton et al., 
2006). This type of lymphoma affects the B-cells of a patient’s blood, and is an 
aggressive, fast growing tumor. There are multiple forms of this cancer, most of which 
are determined by where the tumors are located in the body, and which other cells are 
involved. Although treatment has greatly improved, around fifty percent of patients do 
not respond to current chemotherapy treatments, or they relapse after treatment (Shipp et 
al., 2002).  The cause of this lymphoma is still not known (Ramkumar et al., 2013). 
Knowing the cause would help determine therapeutic targets to form more effective 
treatments.  
 
The Zhang Laboratory 
 Recently, the Zhang laboratory at the University of Massachusetts Medical 
School has found that the Smurf2 gene plays a role in the regulation of B-cell 
proliferation, and in the development of diffuse large B-cell lymphoma. Smurf2 is an E3 
ubiquitin ligase protein which mediates the degradation of proteins associated with tumor 
formation (Ramkumar et al., 2012). Using Smurf2-knockout mice, the Zhang laboratory 
demonstrated that Smurf2 deficiency decreased the expression of p16, a known tumor 
suppressor. In addition, the Zhang laboratory found that when Smurf2 was suppressed, by 
either complete knockout or heterozygous knockout, mouse embryonic fibroblasts 
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showed an impaired senescence response and became immortalized (Ramkumar et al., 
2012) (Figure 1). 
 
 
 
 
 
 
 
 
 
Figure-1: Impaired Senescence in Smurf2-Deficient MEF’s.  Panels B and C 
show that mouse embryo fibroblast cells lacking Smurf2 (T/T or +/T) show 
increased population doublings compared to WT cells.  Panels D and F show that 
cells lacking Smurf2 have an increased expression of p21 and a decreased 
expression of p16 tumor suppressor (Ramkumar et al., 2012) 
 
Using the same knockout mice, the Zhang lab also showed that Smurf2-deficient 
mice show splenomegaly and develop tumors spontaneously at a far greater rate than WT 
mice (Figure-2). While the WT mice showed no tumor formation over 20 weeks, the 
heterozygous Smurf2 knockout mice showed a 23.8% tumor development, and the 
homozygous Smurf2 knockout mice showed a 30.6% rate of tumor development. Of the 
tumors that formed, 72.7% were lymphomas (Ramkumar et al., 2012). 
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Figure-2: Increased Spontaneous Tumor Formation in 
Smurf2-Deficient Mice.  Panel A shows the tumor free survival 
rates of WT (+/+), heterozygous Smurf2-KO (+/T) and 
homozygous Smurf2-KO (T/T) mice. Only the WT mice remain 
tumor-free.  Panel B shows the spleen size of T/T and age-
matched WT mice, the T/T mice show splenomegaly. Panel C 
shows H&E staining and B220 staining of lymphomas in spleen, 
liver, and kidneys of T/T and WT +/+ mice (Ramkumar et al., 
2012). 
 
The Smurf2 knockout was also found to inhibit spleen senescence (Figure-3). In 
premalignant 12 week old mice, the senescence response was inhibited in Smurf2 
deficient mice compared to the same age wild type mice. It was also found that p16, an 
important tumor suppressor, was decreased in Smurf2-deficient mice, while protein Id1 
was increased.  Thus, Smurf2 plays a role in senescence through the Smurf2-Id1-p16 
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tumor suppressor pathway to induce senescence, which could explain why Smurf2 
deficiency promotes spontaneous tumor formation (Ramkumar et al., 2012). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure-3: Impaired Senescence Response in Spleens of Aged 
Smurf2-Deficient Mice.  Panel A shows SA- β-gal activity of WT 
(+/+) and homozygous Smurf2-KO (T/T) mice, indicating a decrease in 
senescence in T/T mice. Panel B shows Western and RT-PCR analyses 
of p16 levels in WT (+/+) and Smurf2-KO (T/T) mice, showing a 
decrease in p16 levels in KO mice (Ramkumar et al., 2012). 
   
In their next paper (Ramkumar et al., 2013), the Zhang laboratory further 
examined the role of Smurf2 in the development of diffuse large B-cell lymphoma. In 
this study, they demonstrated that Smurf2 is also involved in the YY1-c-Myc pathway. 
YY1 is a germinal center transcription factor that trans-activates the transcription of c-
Myc (Ramkumar et al., 2013).  c-Myc is an oncogene that is critical for human 
development.  It is also known that c-Myc plays a crucial role in the cell cycle, 
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prolonging the doubling time of rat fibroblast cells when removed (Dang, 1999). c-Myc 
is known to play a large role in the development of cancer, with an estimated 70,000 
cancer deaths per year associated with c-Myc mutations or changes in c-Myc expression 
(Dang, 1999).  
In their experiment, the Zhang laboratory showed that Smurf2 regulated the 
stability of YY1, showing that Smurf2 is responsible for mediating the ubiquination and 
degradation of YY1 (Figure-4). They demonstrate that Smurf2-deficient  
 
 
Figure-4: Smurf2 Regulates the Stability of Protein YY1.  Panel A shows the 
expression of YY1 transcription factor in WT (+/+) spleens compared to age-
matched lymphomas using Western analysis.  YY1 is increased in the 
lymphomas.  Panel B shows the expression of YY1 in spleens of 2-month old 
WT mice and Smurf2-KO (T/T) mice.  YY1 increases in the KO mice 
(Ramkumar et al., 2013). 
 
 To further show that Smurf2 plays a crucial role in the YY1-c-Myc pathway, the 
Zhang lab examined the c-Myc levels in Smurf2-deficient mice compared to wild type 
mice. Their results (Figure-5) showed that Smurf2-deficient mice with increased levels 
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of YY1 also show increased levels of c-Myc. Thus, there is a direct correlation between 
Smurf2 expression and the expression of oncogene c-Myc, which is mediated by the 
Smurf2-YY1-c-Myc pathway (Ramkumar et al., 2013).  
 
 
 
 
 
 
 
 
 
 
 
Figure-5: Elevated c-Myc Expression in Smurf2-Deficient Mice. Panel A 
shows that lymphomas in Smurf2-KO (T/T) and (+/T) mice demonstrate an 
increased expression of c-Myc compared to aged WT (+/+) mice. Panel B shows 
that c-Myc expression is increased in the spleens of 2-month old T/T mice 
compared to WT (+/+) mice (Ramkumar et al., 2013). 
 
 Having established that the Smurf2-YY1 pathway helps regulate the expression of 
the oncogene c-Myc, the Zhang laboratory then examined human diffuse large B-cell 
lymphoma tumors for Smurf2 expression (Figure-6). They found that Smurf2 expression 
directly correlates with patient survival probability. In particular, they found that 
decreased levels of Smurf2 expression in human tumors correlated to a poorer survival 
prognosis (Ramkumar et al., 2013).  
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Figure-6: Smurf2 Expression Correlates With Overall Survival of Human 
DLBCL Patients. Panel A shows that Smurf2 expression in human lymphomas 
is decreased when compared to normal B cells. Panels B-D show that in human 
diffuse large B-cell lymphoma tumors, when Smurf2 expression is low, the 
patient survival prognosis is poor (Ramkumar et al., 2013). 
 
 Altogether, the Zhang laboratory’s findings demonstrate that the loss of Smurf2 
plays a crucial role in the development of diffuse large b-cell lymphomas, playing two 
roles in tumor suppression: 1) increasing senescence through the Smurf2-Id1-p16 
pathway, and 2) suppressing oncogene c-Myc through the degradation of YY1 using the 
Smurf2-YY1-c-Myc pathway, which can result in the spontaneous development of 
diffuse large B-cell lymphomas.  
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The VH4 Family 
 The variable heavy-4 (VH4 or VH4) gene family encodes a portion of the variable 
heavy chain present in the immunoglobulin gene. Variable heavy, and variable light (VL) 
chains are formed through recombination of the V (D) and J gene segments, as well as 
random pairing of the heavy and light chains (Bende et al., 2002).  Additional variability 
is added through class switch recombination and through somatic hyper-mutation. All of 
these gene rearrangements and mutations occur so that during the course of a normal 
humoral response, specific antibodies can become selected for their affinity to a pathogen 
(Schrader et al., 2013). In the V regions of the Ig genes, however, somatic hyper-
mutation is the most likely cause of diversity. The VH4 intron is the upstream leader 
primer of the VH region (Figure-7). The VH region is also known to be associated with 
multiple forms of lymphoma. In particular, the IgVh region has been shown to be 
involved in two V4-34-expressing lymphomas, a follicular lymphoma, and a V4-34 
expressing diffuse large B-cell lymphoma (Bende et al., 2002).  Because mutations in the 
VH4 intron locus have previously been associated with diffuse large B-cell lymphomas, 
we chose to analyze whether mutations in this locus might be induced by Smurf-2 
knockout in mice. 
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Figure-7: The IgH Locus.  Panel A shows the IgH locus, and the VH region of 
this locus. The VH4 intron (white arrow, upper left side) can be seen as the lead 
primer on the upstream end of the VH region.  (Bende et al., 2002) 
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Project Purpose 
 
The purpose of this project was to clone and sequence the VH4 Intron portion of 
spleen germinal center cells in Smurf-2 knockout mice to determine whether mice 
lacking Smurf2 show increased mutation rates at this locus prior to tumor formation.  
Mutations in the VH4 locus (Bende et al., 2002) and decreased levels of Smurf2 
(Ramkumar et al., 2013) have both previously been associated with the formation of 
diffuse large B-cell lymphomas.  The VH4 intron is the lead upstream primer to the 
variable heavy region of the IgH locus.  In this position, mutations to the VH4 locus 
could disrupt transcription of the variable heavy region of the IgH locus, or could disrupt 
the effects of somatic hyper-mutation on this region. 
 The germinal center B-cells within the spleen will be isolated by FACS sorting 
for cellular markers B220+, CD95+, and GL7+ which are markers for germinal center B-
cells (Schader et al., 2013).  Genomic DNA will be isolated from these cells in WT and in 
Smurf2-KO mice before and after tumor formation, and then PCR will be used to amplify 
a 600 bp amplicon of the VH4 intron locus.  The amplicons will be d3’ tailed, cloned into 
a TOPO plasmid, and sequenced. 
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Methods 
 
Fluorescent Activated Cell Sorting 
Wild type and Smurf2 knock mice were provided by the Zhang lab.  The spleens 
from six week old un-immunized WT and Smurf2-knockout mice were minced using the 
rough edges of two Fisherbrand slides. The crushed spleens were then mixed with 
staining reagent, and centrifuged for 6 minutes at 1300 RPM. This was aspirated to 100 
uL, and vortexed.  To lyse the red blood cells, 9.0 mL of cold Tcd water was added to the 
pellet, and mixed well. 1.0 mL of 10X PBS was then added, and mixed well. SM was 
then added to the mixture, filling to 13 mL. Using a nylon mesh filter, tissue and dead 
cell debris were removed from the mixture. Around 1 mL of newborn calf serum was 
then applied to make a layer on the bottom of the tube. This was then spun for 6 minutes 
at 1300 RPM, and the supernatant was aspirated off.  The cells were then re-suspended in 
10 mL of SM buffer, and subjected to FACS analysis at the University of Massachusetts 
Medical School (UMMS), selecting for cellular markers B220+, CD95+, and GL7+ 
which are markers for Germinal Center B-Cells (Schader et al., 2013). 
 
Isolation of Genomic DNA 
To isolate genomic DNA, the cell pellet was re-suspended in 100 uL STE buffer 
(0.1M NaCl, 20 mM Tris pH 8.0, 1mM EDTA), 5 uL proteinase K, and 2.5 uL 20% SDS. 
This was placed at 55°C for 2 hours. This was then cooled, spun down quickly, and a 
mixture of 15 uL 3M sodium acetate at pH 5.2 and 450 uL of 95% EtOH was added. This 
was left at -20°C overnight, and then spun at 14,000 RPM, at 4°C for 30 minutes. The 
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EtOH was poured off, and 500 uL 70% EtOH was added. This was then spun down at 
14,000 RPM at 4°C for 10 minutes, and allowed to air dry for around 5 minutes. The 
pellet was then re-suspended in 20 uL TE-4 (10 mM Tris pH 7.4, 0.1 mM EDTA). 
 
Nested PCR of FACS Product 
Following the isolation of genomic DNA, a nested PCR was performed to amplify 
a 600 base pair amplicon in the VH4 intron DNA. The first amplification used the 
forward primer 5’ AGCCTGACAT-ACTGAGGAG and the reverse primer 
5’GTGTTCCTTT-GAAAGCTGGAC.  Phusion (New England Biolabs Inc.) was used as 
the polymerase instead of Taq, due to its higher fidelity, and Phusion buffer, dNTP’s, and 
the genomic DNA.  Water was used as a control. The reaction conditions were 95°C for 
30 seconds, 57°C for 30 seconds, 72°C for 1 minute, and this was repeated for 30 cycles. 
The second PCR amplification used the same reagents, but the forward primer was 5’ 
CCGGAATTCCTGACATCTGAGGACTCTGC, and the reverse primer was 5’ 
GATGCCTTTCTCCCTTGACTC.  The reaction conditions were also the same as the 
first amplification, but run for 35 cycles instead of 30 (Schrader et al., 2013).  
 
Gel Electrophoresis of PCR Amplicons and Band Extraction 
The PCR products of the second PCR were electrophoresed in a 1% agarose gel. 
The PCR reactions were loaded into the gel using a blue loading dye, and were run at 70 
volts for about one hour.  Following electrophoresis, the bands at the 600 base pair range 
for each lane were removed using a scalpel. They were placed into previously weighed 
tubes, and were then weighed again to determine the weight of the extracted band. After 
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this, gel extraction was performed in order to remove the DNA from the agarose using 
the Qiagen QIAquick Gel Extraction Kit. The gel was first dissolved using buffer QG in a 
50°C water bath.  After the gel was completely dissolved, isopropanol was added to the 
sample and mixed. This mixture was then added to the QIAquick spin column, where the 
DNA absorbs to the silica gel of the column, and contaminants pass through the column.  
The column wash was spun down, and QG buffer was added once more, and spun down 
again.  Buffer PE was then added, and the column was spun down twice.  Elution Buffer 
EB was then added, and the column was spun down to elute the purified amplicon DNA 
from the QIAquick spin column. 
 
dA Tail Extension 
After the gel extraction of amplicon DNA, a 3’ dA extension was performed to 
add a short adenosine tail to the DNA to facilitate cloning. To perform this, each gel 
extraction product was mixed with 1 μl of Taq, and 1 μl of dNTPs. The reaction 
conditions used for this extension were 72°C for 10 minutes, and then cooled to 4°C for 2 
minutes.  Following the extension, the DNA with a 3’ dA tail was purified again using 
the Qiagen QIAquick gel extension kit. The same protocol was used as before, skipping 
the initial dissolving of the gel in 50°C water.  
 
TOPO Cloning 
Following purification of the dA-tailed amplicon, the DNA was cloned into a 
TOPO plasmid to facilitate sequencing using the Invitrogen TOPO TA cloning kit.  4.0 μl 
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of the amplicon DNA was added to 1 μl of salt solution, and 1 microliter of TOPO 
vector, to a final volume of 6 μl. This was incubated for 5 minutes at room temperature. 
Immediately following the incubation, the mixture was placed on ice. The solution was 
then transfected into Mach1-T1 competent E. coli cells using the Transform One Shot 
Invitrogen protocol.  2 μl of the solution was added to the E. coli cells provided. This 
mixture was incubated on ice for 5 minutes, heat shocked at 42°C in a hot water bath for 
30 seconds, and then placed back on ice. 250 μl of room temperature S.O.C. medium was 
then added, and the mixture was shaken gently for one hour at room temperature. 100 μl 
of the mixture was then added to pre-warmed LB ampicillin selective plates, and these 
were left to incubate overnight at 37°C.    
 
Miniprep DNA Isolation 
After the transfection and plating, three random colonies were chosen from each 
plate based on their color, size, and shape (circular, with a solid outline). These colonies 
were then placed into separate LB media in test tubes and pelleted.  The cell pellet was 
then added to Buffer P1 and resuspended.  Buffer P2 was then added, and the solution 
was mixed by inversion. After no more than 5 minutes, Buffer N3 was added, and the 
solution was again mixed gently by inversion. This was then centrifuged for 10 minutes 
at 13,000 RPM, and the supernatant was applied directly to the QIAquick Spin column. 
This was then centrifuged for 60 seconds, and then washed with buffer PB, and 
centrifuged again for 60 seconds. The column was washed again using buffer PE and 
centrifuged. The flow-through was discarded, and the column was centrifuged once more 
for 60 seconds. Finally, the DNA was eluted by applying water directly to the center of 
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the column, allowing the column to sit for one minute, and then centrifuged for one 
minute.  
 
DNA Sequencing 
The purified plasmids were sent to Macrogen USA to be sequenced. Upon 
receiving the sequence results, they were examined using MacVector software to identify 
potential mutations. 
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RESULTS 
 
In this project, we attempted to isolate the germinal center cells containing B-cells 
from the spleens of WT and Smurf2-knockout mice, amplify the VH4 intron region by 
PCR, and clone and sequence the amplicons to determine whether DNA mutations at this 
locus precedes cancer formation.  The first thing we did was to isolate the germinal center 
cells from 6-week old spleens from WT and Smurf2-KO mice using FACS (Figures 7 
and 8).  The markers used to select for the germinal center cells were B220+, CD95+, 
and GL7+, which when all three are present represent a strong selection for germinal 
center cells (Schrader et al., 2013). The data show that we were able to obtain a usable 
amount of germinal center cells from the spleens of unimmunized mice.  The data also 
show that immunizing the mice with NP-chicken gamma-globulin or isolating Peyer’s 
Patch cells is not needed to obtain a usable amount of material. 
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Figure-7: FACS Analysis of Spleen Cells in Wild Type Mice.  
Shown are the sorting data for B220+, CD95+, and GL7+ 
markers indicating germinal center cells.  
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Figure 8: FACS analysis of Spleen Cells in Smurf2-Knockout 
Mice.  Shown are the data sorting for B220+, CD95+, and GL7+ 
markers indicating germinal center cells.  
 
 
Genomic DNA was isolated from the spleen germinal center cells, and was then 
used in a nested PCR to amplify the VH4 intron locus.  Based on the primers used, we 
expected amplicons of approximately 600 bp (Figure-9).  Amplicons of the correct size 
were obtained for WT and Smurf2-KO samples (blue arrow in the figure), although the 
amplicons were not discrete and appeared as smears. 
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Figure-9: Nested PCR of the VH4 Intron Locus of DNA 
Isolated from Germinal Center Cells.  Lane 1 (on the right) is 
a DNA ladder; Lanes 2 and 3, Smurf 2-knockout; Lane 4, WT; 
Lane-5, negative control (dH2O). The 600 bp range where the 
amplicons were excised from is denoted by a blue arrow. 
Amplicons were excised from lanes 2, 3, and 4. 
 
 
Following the PCR, a band gel extraction was performed to extract the DNA from 
the gel, and 3’ dA tails were added to the amplicons using Taq polymerase to facilitate 
cloning in the TOPO dT-tailed vector.  Unfortunately, it was not determined in advance 
whether a sufficient amount of amplicon DNA was obtained for cloning, so this could 
have caused a problem with the cloning from the outset.  In addition, the serious 
smearing of the amplicons could also have caused cloning problems.  The 3’ dA-tailed 
DNA was purified again, and then ligated into a T-tailed TOPO plasmid vector.  The 
ligated samples were transformed into competent E. coli cells provided with the cloning 
kit. Three “positive” colonies from each selection plate were used to purify plasmid 
DNA, which was then sent for sequencing analysis at Macrogen USA.   
The sequence information was analyzed using MacVector software.   
Unfortunately, the transformation of the bacteria did not occur properly.  Although 
5     4    3    2    1 
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“positive” ampicillin-resistant colonies were found on the plates, the sequence data 
indicated that no VH4 intron was inserted. Because of this we were unable to determine 
whether there was an increased mutation rate in the VH4 intron region of the germinal 
center DNA when Smurf2 is knocked out in mice, so that remains a future experiment. 
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DISCUSSION 
 
The purpose of this project was to determine whether the mutation rate in the 
VH4 intron region increases when Smurf2 is knocked out in mice.  Unfortunately, we 
were unable to achieve this goal because we were unable to successfully clone the VH4 
locus.  Because of this, we were not able to successfully make any conclusions about the 
main purpose of the project.  
However, the FACS analysis appeared to work well.  We determined that the 
spleens of non-immunized six week old mice (WT and Smurf2-KO) allow the isolation 
of a sufficient amount of germinal center cells to isolate genomic DNA.  Thus, 
immunization with NP-chicken gamma-globulin was not needed to boost the B-cell yield, 
which could have been problematic when performing future projects. If immunized mice 
were used, their germinal center cells reproduce at a very high rate, increasing the 
likelihood of natural DNA mutations which could obscure the mutations induced by the 
Smurf2 KO. 
PCR was the main problem encountered in this project.  In many cases, a 600 bp 
band appeared in the negative control samples which were the same size DNA as the 
expected VH4 intron amplicon. After extensive testing of the reagents, we found the 
source of this contamination to be in the micropipettes. However, even after eliminating 
the pipette contamination other contaminations remained, likely from the dH2O samples 
used in the PCR reactions.  In addition, the amplicons when they did appear were smears 
and not clear discrete strong bands, so this too could have caused cloning problems.  In 
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the future, the isolated genomic DNA should be tested for quality by determining whether 
primers for other genes work well.  If so, the problem lies with the VH4 primers. 
The other problem encountered in this project came from not being able to 
transfect a sufficient amount of plasmid containing the VH4 intron into the E. coli to 
obtain a high number of “positive” colonies on the plates. This could have been caused 
by very low yields of amplicon DNA resulting from the contamination mentioned 
previously, or from the low transformation efficiency (TFE) of the competent cells used.  
In the future, a different strain of bacteria will be tested for transfection, or a new batch of 
commercial highly competent cells will be tested. 
Due to its scientific importance, this project should be continued.  As mentioned 
in the Background section, our laboratory has shown that Smurf2 knockout in mice 
causes the spontaneous development of B-cell tumors closely resembling diffuse large B-
cell lymphoma in humans; and suppressed Smurf2 expression in human diffuse large B-
cell Lymphoma tumors correlates with a poor patient prognosis (Ramkumar et al., 2013). 
This clearly shows that the Smurf2 pathway plays a major role in the progression of these 
lymphomas, so it is necessary to better understand what the suppression of Smurf2 
expression does to B-cells, and how it may affect DNA mutations.  In future projects, it 
would be necessary to ensure that a sufficient amount of high-quality genomic DNA is 
obtained from the spleen cells (PCR for genes other than VH4 could be used as positive 
controls), to test other VH4 primers until a strong discrete amplicon is obtained, to make 
sure the gel purification protocols provide a high yield of amplicon DNA, and to switch 
to other commercially available strains of high TFE competent cells for the 
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transformation experiments. Finally, using a different method for selection other than 
ampicillin resistance may more accurately select true positives. 
 28 
Bibliography 
Bende RJ, Aarts, WM, Pals ST, van Noesel CJM (2002) Immunoglobulin diversification 
in B cell malignancies: internal splicing of heavy chain variable region as a by-product of 
somatic hyper-mutation. Leukemia, 16: 636-644. 
 
Dang CV (1999) c-Myc Target Genes Involved in Cell Growth, Apoptosis, and 
Metabolism. Molecular Cell Biology, 19: 1-11. 
 
Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS (2006) 
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood, 
107 (1): 265–276.  
 
Ramkumar C, Kong Y, Cui H, Hao S, Jones SN, Gerstein RM, Zhang H (2012) Smurf2 
regulates the senescence response and suppresses tumorigenesis in mice.  Cancer 
Research, 72(11): 2714-2719.  
 
Ramkumar C, Cui H, Kong Y, Jones SN, Gerstein RM, Zhang H (2013) Smurf2 
suppresses B-cell proliferation and lymphomagenesis by mediating ubiquitination and 
degradation of YY1.  Nature Communications, 4: 2598. doi: 10.1038/ncomms3598. 
 
Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, Gaasenbeek M, 
Angelo M, Reich M, Pinkus GS, Ray TS, Koval MA, Last KW, Norton A, Lister TA, 
Mesirov J, Neuberg DS, Lander ES, Aster JC, Golub TR (2002) Diffuse large B-cell 
lymphoma outcome prediction by gene-expression profiling and supervised machine 
learning. Nature Medicine: 8(1): 68-74. 
 
Schrader CE, Linehan EK, Ucher AJ, Bertocci B, Stavnezer J (2013) DNA polymerases β 
and λ do not directly affect Ig variable region somatic hypermutation although their 
absence reduces the frequency of mutations. DNA Repair, 12(12): 1087-1093. 
 
 
 
